NCT03215732

Brief Summary

This study aims at estimating the prevalence of chronic hepatitis B virus (HBV) infection in rural Senegal (area of Niakhar) and at evaluating the associated burden in terms of both health-related and socio-economic consequences.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,119

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 10, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 12, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

October 19, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2019

Completed
Last Updated

September 9, 2019

Status Verified

September 1, 2019

Enrollment Period

1.8 years

First QC Date

July 10, 2017

Last Update Submit

September 6, 2019

Conditions

Keywords

prevalencevaccine coveragerisk factorsmorbiditymortalityquality of lifeeconomic vulnerabilityfood securitytreatment needsdecentralized carehealth costscaregivers training

Outcome Measures

Primary Outcomes (1)

  • Prevalence of chronic HBV infection

    HBs Ag positivity with a positive anti-HBc antibody and a negative anti-HBs antibody

    At baseline

Secondary Outcomes (10)

  • Prevalence of chronic HBV infection in age classes '0-15 years; 15-35 years, more than 35 years), and in women of childbearing age

    At baseline

  • HBV vaccine coverage (in children born after 2004, year of the introduction of the vaccine in the national program)

    At baseline

  • HBV vaccine efficacy (in children born after 2004, year of the introduction of the vaccine in the national program)

    At baseline

  • Mortality associated with chronic HBV infection in the Niakhar area

    6 months

  • Morbidity associated with chronic HBV infection in the Niakhar area

    6 months

  • +5 more secondary outcomes

Interventions

Survey participants will be tested at home for chronic HBV infection using the DBS technique (collection of drops of whole blood dried onto filter paper).

Eligibility Criteria

Age6 Months+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

The study population will include all individuals who live (even non-permanently) in the sampled households of the Niakhar area for at least 6 months, who are aged of at least 6 months, and who sign informed consent to participate in the survey.

You may qualify if:

  • (i) Living in a household of the research zone (individuals living within participating households for at least 6 months, even non permanently: seasonal workers or individuals studying outside the Niakhar zone)
  • (ii) Being aged of at least 6 months
  • (iii) Giving informed consent to participate in the research

You may not qualify if:

  • (i) Being an adult unable to sign informed consent
  • (ii) Being a child whose parents or legal guardian is not present in the household at the time of the survey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

At home

Niakhar, Fatick, Senegal

Location

Related Publications (2)

  • Djaogol T, Perieres L, Marcellin F, Diouf A, Carrieri MP, Diallo A, Boyer S; ANRS 12356 AmBASS Study Group. Hepatitis B prevention and treatment needs in women in Senegal (ANRS 12356 AmBASS survey). BMC Public Health. 2023 May 5;23(1):825. doi: 10.1186/s12889-023-15710-y.

  • Coste M, De Seze M, Diallo A, Carrieri MP, Marcellin F, Boyer S; ANRS 12356 AmBASS Study Group. Burden and impacts of chronic hepatitis B infection in rural Senegal: study protocol of a cross-sectional survey in the area of Niakhar (AmBASS ANRS 12356). BMJ Open. 2019 Jul 17;9(7):e030211. doi: 10.1136/bmjopen-2019-030211.

MeSH Terms

Conditions

Hepatitis B, Chronic

Condition Hierarchy (Ancestors)

Hepatitis BBlood-Borne InfectionsCommunicable DiseasesInfectionsHepadnaviridae InfectionsDNA Virus InfectionsVirus DiseasesHepatitis, Viral, HumanHepatitis, ChronicHepatitisLiver DiseasesDigestive System DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sylvie BOYER, Dr

    Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, Marseille, France

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 10, 2017

First Posted

July 12, 2017

Study Start

October 19, 2017

Primary Completion

July 31, 2019

Study Completion

July 31, 2019

Last Updated

September 9, 2019

Record last verified: 2019-09

Data Sharing

IPD Sharing
Will not share

Locations